HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
H Sofen Selected Research
H Sofen Research Topics
Disease
13
Psoriasis (Pustulosis Palmaris et Plantaris)
12/2021 - 12/2013
1
Atopic Dermatitis (Atopic Eczema)
10/2019
1
Eczema
10/2019
1
Inflammation (Inflammations)
10/2019
1
Pruritus (Itching)
10/2019
1
Atherosclerosis
10/2019
1
Psoriatic Arthritis
10/2017
1
Angioedema
06/2017
1
Urticaria (Hives)
06/2017
1
Nail Diseases (Nail Disease)
02/2014
1
Melanoma (Melanoma, Malignant)
04/2011
Drug/Important Bio-Agent (IBA)
3
Monoclonal Antibodies
IBA
12/2019 - 02/2015
3
ixekizumab
IBA
01/2018 - 06/2017
3
Ustekinumab (CNTO 1275)
FDA Link
10/2017 - 12/2013
2
tildrakizumab
IBA
12/2019 - 10/2019
2
Biomarkers (Surrogate Marker)
IBA
10/2019 - 04/2011
2
secukinumab
IBA
10/2017 - 02/2015
2
tofacitinib
IBA
02/2017 - 01/2015
2
Janus Kinase Inhibitors
IBA
02/2017 - 01/2015
2
Prostaglandins A
IBA
01/2015 - 02/2014
1
Certolizumab Pegol
FDA Link
12/2021
1
apremilast
IBA
10/2021
1
Janus Kinases
IBA
10/2019
1
gusacitinib
IBA
10/2019
1
Syk Kinase
IBA
10/2019
1
E-Selectin
IBA
10/2019
1
Etanercept (Enbrel)
FDA Link
11/2017
1
Interleukin-17 (Interleukin 17)
IBA
10/2017
1
Omalizumab (Xolair)
FDA Link
06/2017
1
Immunoglobulin A (IgA)
IBA
02/2015
Therapy/Procedure
2
Retreatment
02/2017 - 01/2015
1
Therapeutics
06/2017
1
Subcutaneous Injections
02/2015